Clinical Biomarkers and Pathogenic-Related Cytokines in Rheumatoid Arthritis
Joint Authors
Source
Journal of Immunology Research
Issue
Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2014-08-21
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Rheumatoid arthritis (RA) is a common autoimmune disease with unknown etiology and pathogenesis.
Although major therapeutic advances have been made in recent years, there is no cure for the disease.
Current medications mainly reduce inflammation in order to relieve pain and slow joint damage, but many have potentially serious side effects.
Therefore, to find specific biomarkers will benefit both RA patients to find relief from the disease and physicians to monitor the disease development.
A number of biomarkers have been discovered and used clinically, and others are still under investigation.
The autoantibodies, which are widely used in diagnosis and prognosis, novel biomarkers, which reflect clinical disease activity, and newly found biomarkers and pathogenic-related cytokines are discussed in this review.
American Psychological Association (APA)
Niu, Xiaoyin& Chen, Guangjie. 2014. Clinical Biomarkers and Pathogenic-Related Cytokines in Rheumatoid Arthritis. Journal of Immunology Research،Vol. 2014, no. 2014, pp.1-7.
https://search.emarefa.net/detail/BIM-1040964
Modern Language Association (MLA)
Niu, Xiaoyin& Chen, Guangjie. Clinical Biomarkers and Pathogenic-Related Cytokines in Rheumatoid Arthritis. Journal of Immunology Research No. 2014 (2014), pp.1-7.
https://search.emarefa.net/detail/BIM-1040964
American Medical Association (AMA)
Niu, Xiaoyin& Chen, Guangjie. Clinical Biomarkers and Pathogenic-Related Cytokines in Rheumatoid Arthritis. Journal of Immunology Research. 2014. Vol. 2014, no. 2014, pp.1-7.
https://search.emarefa.net/detail/BIM-1040964
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1040964